Press Releases

NEW YORK, Jan. 21, 2020 /PRNewswire/ -- Ride Health, coordinating smarter transportation for every patient need, and

Read more...

NEW YORK, Jan. 21, 2020 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company focused on developing new generation therapies for dermatological and immunological disorders such as atopic dermatitis, psoriasis, asthma and acne, announced today that the Company has concluded its "In-life 28-day animal study" for their BioLexa Platform.&nb

Read more...

PITTSBURGH, Jan. 21, 2020 /PRNewswire/ -- ANSYS (NASDAQ: ANSS) is paving the

Read more...

ARTARMON, Australia, Jan. 21, 2020 /PRNewswire/ -- Saluda Medical Pty Limited ("Saluda Medical") today announced that data from multiple studies evaluating the company's Evoke® ECAP-Controlled, Closed-Loop Spinal Cord Stimulation (SCS) System for the treatment of chronic pain will be featured in multiple presentations – including eight oral presentat

Read more...

LOS ANGELES, Jan. 21, 2020 /PRNewswire/ -- With a rising trend in the consumerism of healthcare, as well as a broad public adoption of smart devices and IoT connected technologies, premier healthcare providers are entrusting

Read more...

LUND, Sweden, Jan. 21, 2020 /PRNewswire/ -- Diaprost entered into an exclusive Research and Option Agreement with a Top 10 Pharmaceutical company strategic partner in October 2017. Diaprost now announces that its strategic partner has exercised its option to acquire rights to its h11B6 antibody.An upfront payment and research fun

Read more...

TAIPEI, Taiwan, Jan. 21, 2020 /PRNewswire/ -- OBI Pharma, Inc., a Taiwan biopharma company (TPEx: 4174), today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for OBI-999 for the treatment of Gastric Cancer. OBI-999 is a first-in-class antibody drug conjugate targeting Globo H, a glycoli

Read more...

HARBIN, China, Jan. 20, 2020 /PRNewswire/ -- At the beginning of 2020, GNC, a U.S.-based brand, announced its collaborative partnership with Renmintongtai, the pharmacy chain of Harbin Pharmaceutical Group, and launched four "blue hat" products, which refers to nutritional supplements products certificated b

Read more...

ALEXANDRIA, Va., Jan. 20, 2020 /PRNewswire/ -- In the aftermath of multiple high-magnitude earthquakes that hit Puerto Rico last week, The Salvation Army is providing physical, emotional and spiritual care to individuals and families impacted by the disaster, as well as first responders.

Read more...

SAN DIEGO, Jan. 20, 2020 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced today that it will report fourth quarter and year-end 2019 financial results after the Nasdaq market closes on Tuesday, Feb. 4, 2020. Neurocrine will then host a conference call and webcast to discuss its financial results and provide a company upd

Read more...